Correlation Between Pyxis Oncology and Prelude Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pyxis Oncology and Prelude Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pyxis Oncology and Prelude Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pyxis Oncology and Prelude Therapeutics, you can compare the effects of market volatilities on Pyxis Oncology and Prelude Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pyxis Oncology with a short position of Prelude Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pyxis Oncology and Prelude Therapeutics.
Diversification Opportunities for Pyxis Oncology and Prelude Therapeutics
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Pyxis and Prelude is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Pyxis Oncology and Prelude Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prelude Therapeutics and Pyxis Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pyxis Oncology are associated (or correlated) with Prelude Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prelude Therapeutics has no effect on the direction of Pyxis Oncology i.e., Pyxis Oncology and Prelude Therapeutics go up and down completely randomly.
Pair Corralation between Pyxis Oncology and Prelude Therapeutics
Given the investment horizon of 90 days Pyxis Oncology is expected to generate 1.87 times less return on investment than Prelude Therapeutics. But when comparing it to its historical volatility, Pyxis Oncology is 6.2 times less risky than Prelude Therapeutics. It trades about 0.36 of its potential returns per unit of risk. Prelude Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 171.00 in Prelude Therapeutics on August 28, 2025 and sell it today you would lose (12.00) from holding Prelude Therapeutics or give up 7.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pyxis Oncology vs. Prelude Therapeutics
Performance |
| Timeline |
| Pyxis Oncology |
| Prelude Therapeutics |
Pyxis Oncology and Prelude Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pyxis Oncology and Prelude Therapeutics
The main advantage of trading using opposite Pyxis Oncology and Prelude Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pyxis Oncology position performs unexpectedly, Prelude Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prelude Therapeutics will offset losses from the drop in Prelude Therapeutics' long position.| Pyxis Oncology vs. Doman Building Materials | Pyxis Oncology vs. Compagnie Plastic Omnium | Pyxis Oncology vs. Eagle Materials | Pyxis Oncology vs. Kossan Rubber Industries |
| Prelude Therapeutics vs. Sunlands Technology Group | Prelude Therapeutics vs. Natcore Technology | Prelude Therapeutics vs. Gamma Communications plc | Prelude Therapeutics vs. Casio Computer Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |